Dr Krishnan Chakravarthy will be speaking at Drug Delivery West at the Mark Hopkins Intercontinental Hotel in San Francisco in May.

About the Event:

The PODD teams bring to the West Coast a Drug Delivery Design & Partnering Meeting

This inaugural program focuses on meeting the design needs of drug delivery systems from the perspectives of pharma, physicians, patients, investors, as well as KOLs in personalized medicine and digital.

There is an emphasis on how to reduce risk and advance drug delivery technologies for current and future needs. More specifically, we aim to cover the following:

  • Where is the sector going?
  • What are the key principles to reduce failures?
  • What are the unknown, unknowns?
  • How do we design for success and what are the guiding principles?

The conference will dedicate the afternoon of day one for a wide variety of drug delivery presentations. Partnering meetings and networking will be available throughout the meeting.

To summarize what to expect at this meeting:

  1. Engaging discussions focused on addressing trends and current unmet needs in drug delivery, relative to both formulation and device development and design
  2. Opinions and insight from physicians, patients, scientists, investors and industry leaders involved with the development of next generation delivery systems
  3. Key principles of drug delivery design for unmet needs and lessons learned from past designs
  4. Networking opportunities with key decision makers in drug delivery, pharmaceutical, biotechnology and medical device industries
  5. Full afternoon of drug delivery technology presentations
  6. Exhibit area showcasing drug delivery innovators and service providers
Read more

 

 

Bio from the Speakers Page:

Krishnan Chakravarthy, MD, PhD is an assistant clinical professor who specializes in multi-modal pain management. As a pain management specialist, he evaluates, diagnoses and treats all forms of pain.

Dr Chakravarthy completed sub-specialty fellowship training in pain management at Massachusetts General Hospital/Harvard Medical School and residency training in anesthesiology at The Johns Hopkins Hospital in Baltimore, MD. He interned in general medicine at Griffin Hospital (Yale Affiliate) in Derby, Connecticut. He earned his MD, PhD degrees at Jacobs School of Medicine and Biomedical Sciences in Buffalo, NY.

Dr Chakravarthy’s research interests in pain medicine include incorporating new technology into advancing pain care. He is currently focusing on using nanotechnology as an novel system to develop new drug delivery and point of care device platforms to manage chronic pain. Dr Chakravarthy’s research interests also focus on the effect of anesthetics on host immunity. Prior to joining UCSD, he has served as a contractor at the US Centers for Disease Control and Prevention (CDC) where he researched host immunity to influenza virus as a way of developing novel therapeutic and vaccine strategies. His research work has been published in top journals including Anesthesiology, Proceedings of the National Academy of Sciences, and Pain Medicine. His research work has been also featured in Times of India, International Business Times, Futurity, NewsMedical and other national and international venues.

Dr Chakravarthy is also a founder of several biotechnology startup companies in the nanotechnology space, and new drug development focusing on commercializing paradigm-shifting technology in the field of infectious diseases, and chronic pain. He is an active entrepreneur and believes industry plays a critical role in seeing translational science make it to patients.

Dr Chakravarthy currently serves on the editorial board of several national and international peer reviewed journals, and committees on organizations such as the International Neuromodulation Society.